Outcomes from the first two years of the Australian hepatitis C surveillance strategy
DOI:
https://doi.org/10.33321/cdi.2002.26.3Keywords:
hepatitis C, surveillanceAbstract
The objectives of national hepatitis C surveillance are to identify those at risk in order to appropriately target prevention and care programs, and to evaluate the impact of these approaches. In 1998 the Communicable Diseases Network Australia New Zealand (CDNANZ) appointed the Hepatitis C Surveillance Committee to develop and implement approaches for improved hepatitis C surveillance in Australia. The Australian Hepatitis C Surveillance Strategy was endorsed in 1999 and provides a framework for improvements to national hepatitis C surveillance. The strategy covers two main surveillance activities: surveillance of incident and prevalent hepatitis C, and the long-term outcomes of hepatitis C. The committee (now the CDNA Viral Hepatitis Surveillance Committee) has continued to facilitate the implementation of the recommendations proposed. Progress towards improvement of hepatitis C surveillance in Australia includes the development of standard case reporting for hepatitis C, collation of data on incident and prevalent hepatitis C from a range of populations at lower and higher risk of hepatitis C, and collation of data from liver transplant registries. Advances in the implementation of the strategy are incremental. While there is enthusiastic commitment towards improving hepatitis C surveillance in Australia, the number of cases, the capacity and competing priorities of State and Territory health departments has meant that implementation has been challenging, highlighting the difficulties in introducing new systems into an already complex situation. Commun Dis Intell 2002;26:14-22.
Downloads
References
National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia annual surveillance report 2001. National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW.
Review of antenatal HIV and hepatitis C virus (HCV) screening policy and practice in Australia, Australasian Society of HIV Medicine, 12-15 October, Melbourne, 2000.
MacDonald M, Wodak AD, Ali R,Crofts et al. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The collaboration of Australian needle exchanges. Med J Aust 1997;166:237-240.
MacDonald MA, Wodak AD, Dolan KA, van Beek I, Cunningham PH, Kaldor JM. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs Med J Aust 2000;172:57-61.
Law MG on behalf of the Hepatitis C Virus Projections Working Group. Modelling the hepatitis C virus epidemic in Australia. Journal of Gastroenterology and Hepatology 1999;14:1100-1107.
Law MG, Roberts S, Dore GJ, Kaldor JM. Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med Aust 2000;173:403-405.
Downloads
Published
How to Cite
License
Copyright (c) 2002 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
